Annovis Bio Inc (ANVS) is lower by 8.89% Wednesday In Premarket Trading

Annovis Bio Inc (ANVS) has fallen Wednesday morning, with the stock declining -8.89% in pre-market trading to 8.92. ANVS's short-term technical score of 10 indicates that the stock has traded less bullishly over the last month than 90% of stocks on the market. In the Biotechnology industry, which ranks 85 out of 146 industries, Annovis Bio Inc ranks higher than 17% of stocks. Annovis Bio Inc has fallen 1.21% over the past month, closing at $11.05 on January 31. During this period of time, the stock fell as low as $8.87 and as high as $11.64. ANVS has an average analyst recommendation of Strong Buy. The company has an average price target of $39.80.

ANVS has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on ANVS!

See Full ANVS Report

Annovis Bio Inc has a Long-Term Technical rank of 26. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 74% of the market scoring higher. In the Biotechnology industry which is number 47 by this metric, ANVS ranks better than 47% of stocks.

Important Dates for Investors in ANVS:

-Annovis Bio Inc is set to release earnings on 2024-04-01. Over the last 12 months, the company has reported EPS of $-4.84. -We do not have a set dividend date for Annovis Bio Inc at this time. Click Here To Get The Full Report on Annovis Bio Inc (ANVS)